Halaven Injection
Product Images NDC 43624-002

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Halaven (NDC 43624-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bsp Pharmaceuticals Spa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (eribulin Mesylate) Injection1 mg/2 mL(0.5 mg/ml)for Intravenous Use (Eisai Halaven Label)

This is a product label for Halaven, an injection containing the drug eribulin mesylate, manufactured by Eisai Manufacturing Limited in the United Kingdom. The label includes information about storage conditions, expiration date, and lot number. It also indicates that the drug is manufactured for intravenous use and has a strength of 0.5mg/ml, with a total volume of 2ml. The drug is not to be frozen and should be stored at temperatures ranging between 15°C and 25°C. The manufacturer of the drug is BSP Pharmaceuticals SpA, based in Italy.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.